Details for New Drug Application (NDA): 012421
✉ Email this page to a colleague
NDA 012421 describes MEDROL ACETATE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the MEDROL ACETATE profile page.
The generic ingredient in MEDROL ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
The generic ingredient in MEDROL ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for 012421
| Tradename: | MEDROL ACETATE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | methylprednisolone acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.25% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
